Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers

ARID1A is a tumour suppressor gene that is frequently mutated in clear cell and endometrioid carcinomas of the ovary and endometrium and is an important clinical biomarker for novel treatment approaches for patients with ARID1A defects. However, the accuracy of ARID1A immunohistochemistry (IHC) as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalique, Saira, Naidoo, Kalnisha, Attygalle, Ayoma D, Kriplani, Divya, Daley, Frances, Lowe, Anne, Campbell, James, Jones, Thomas, Hubank, Michael, Fenwick, Kerry, Matthews, Nicholas, Rust, Alistair G, Lord, Christopher J, Banerjee, Susana, Natrajan, Rachael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065117/
https://www.ncbi.nlm.nih.gov/pubmed/29659191
http://dx.doi.org/10.1002/cjp2.103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065117/
https://www.ncbi.nlm.nih.gov/pubmed/29659191
http://dx.doi.org/10.1002/cjp2.103

Ejemplares similares